Navigation Links
John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.
Date:4/4/2011

PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced today that John P. Gargiulo has been appointed President and CEO of the company. Effective today, Mr. Gargiulo succeeds Joseph P. Pieroni who is retiring after leading Daiichi Sankyo Group's U.S. commercial operations for the past 14 years.

"John's experiences within the pharmaceutical industry for the past 25 years have prepared him well for his new role and responsibility," said Joseph Pieroni, former President and CEO of Daiichi Sankyo, Inc. "He has been instrumental in building and shaping the company since its inception in 1996, and has touched nearly every aspect of our business operations. His broad industry experience enabled him to learn and grow the commercial operations organization."

Mr. Gargiulo most recently served as Senior Vice President of Commercial Operations, where he oversaw U.S. Marketing, Supply Chain, Managed Markets and New Product Planning. After joining the predecessor organization, Sankyo, in 1995, Gargiulo was instrumental in advancing DSI from a joint venture with Parke-Davis to its current status as a leader in hypertension therapy and with an emerging presence in thrombosis and oncology.

"Joe has been a great leader, and has made DSI a successful company by driving excellence through innovation, integrity and accountability -- and by modeling these core company values himself," said Gargiulo, President and CEO of Daiichi Sankyo, Inc. "I am excited about leading DSI through our next company milestones, and fostering a continuing vision of employee excellence that will drive DSI growth and success."

Prior to joining DSI, Gargiulo held several positions at Lederle Laboratories. He currently serves on the Board of Directors of the national industry trade association, the Pharmaceutical Research and Manufacturers Association (PhRMA), and the National Pharmaceutical Council (NPC), an industry trade group focused on evidence-based medicine.

About Daiichi Sankyo

The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit www.daiichisankyo.com

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is a member of the Daiichi Sankyo Group.  For more information on Daiichi Sankyo, Inc., please visit www.dsi.com.


'/>"/>
SOURCE Daiichi Sankyo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedShape Solutions, Inc. Named ATDC Graduate
2. CardioMEMS, Inc. Named a TAG Top 10 Innovative Technology Company
3. Varian Medical Systems to Exhibit New TrueBeam™ System for Image-Guided Radiotherapy at ChinaMed Exhibition in Beijing
4. Netsmart Technologies Named NACo Premier Partner of the Year
5. R. Lindholm Named to Crux Biomedical Board
6. Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named Woman of the Year by Arthritis Foundation
7. Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader
8. Living Medical eTextbook iPhone App from Projects In Knowledge® Named to Top 20 List of Free Medical Apps
9. Dawn Phillips Named as Vice President, Business Development for Catastrophic & Home Health Services
10. Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomens Association
11. Dynatronics Named Contract Supplier to Amerinets 50,000 Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):